Cargando…

Immunization expands HIV-1 V3-glycan specific B-cells in mice and macaques

Broadly neutralizing monoclonal antibodies protect against HIV-1 infection in animal models, suggesting that a vaccine that elicits them in humans would be effective. However, it has not yet been possible to elicit adequate serologic responses by vaccination. To activate B-cells expressing precursor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Escolano, Amelia, Gristick, Harry B., Abernathy, Morgan E., Merkenschlager, Julia, Gautam, Rajeev, Oliveira, Thiago Y., Pai, Joy, West, Anthony P., Barnes, Christopher O., Cohen, Alexander A., Wang, Haoqing, Golijanin, Jovana, Yost, Daniel, Keeffe, Jennifer R., Wang, Zijun, Zhao, Peng, Yao, Kai-Hui, Bauer, Jens, Nogueira, Lilian, Gao, Han, Voll, Alisa V., Montefiori, David C., Seaman, Michael S., Gazumyan, Anna, Silva, Murillo, McGuire, Andrew T., Stamatatos, Leonidas, Irvine, Darrell J., Wells, Lance, Martin, Malcolm A., Bjorkman, Pamela J., Nussenzweig, Michel C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657810/ https://www.ncbi.nlm.nih.gov/pubmed/31142836 http://dx.doi.org/10.1038/s41586-019-1250-z

Ejemplares similares

HIV-specific humoral immune responses by CRISPR/Cas9-edited B cells
por: Hartweger, Harald, et al.
Publicado: (2019)

A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch
por: Wang, Zijun, et al.
Publicado: (2020)

Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope
por: Abernathy, Morgan E., et al.
Publicado: (2021)

Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
por: Barnes, Christopher O., et al.
Publicado: (2018)

Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies
por: Wang, Haoqing, et al.
Publicado: (2017)

Asymmetric opening of HIV-1 Env bound to CD4 and a coreceptor-mimicking antibody
por: Yang, Zhi, et al.
Publicado: (2019)

A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo
por: Freund, Natalia T., et al.
Publicado: (2015)

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2018)

Structural basis for germline antibody recognition of HIV-1 immunogens
por: Scharf, Louise, et al.
Publicado: (2016)

Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodies
por: Diskin, Ron, et al.
Publicado: (2013)

Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
por: McGuire, Andrew T., et al.
Publicado: (2016)

Partially Open HIV-1 Envelope Structures Exhibit Conformational Changes Relevant for Coreceptor Binding and Fusion
por: Wang, Haoqing, et al.
Publicado: (2018)

Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier
por: Bonsignori, Mattia, et al.
Publicado: (2018)

Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer
por: Yang, Zhi, et al.
Publicado: (2022)

Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
por: Hurlburt, Nicholas K., et al.
Publicado: (2020)

HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
por: Steichen, Jon M., et al.
Publicado: (2016)

Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization
por: Parks, K. Rachael, et al.
Publicado: (2019)

HIV-1 CD4-binding site germline antibody–Env structures inform vaccine design
por: Dam, Kim-Marie A., et al.
Publicado: (2022)

Igβ tyrosine residues contribute to the control of B cell receptor signaling by regulating receptor internalization
por: Gazumyan, Anna, et al.
Publicado: (2006)

Nanoparticles presenting clusters of CD4 expose a universal vulnerability of HIV-1 by mimicking target cells
por: Hoffmann, Magnus A. G., et al.
Publicado: (2020)

‘Immunization during ART and ATI for HIV-1 vaccine discovery/development’
por: Stamatatos, Leonidas
Publicado: (2023)

53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination
por: Bothmer, Anne, et al.
Publicado: (2010)

Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
por: Schoofs, Till, et al.
Publicado: (2019)

A naturally arising broad and potent CD4-binding site antibody with low somatic mutation
por: Barnes, Christopher O., et al.
Publicado: (2022)

Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
por: Ding, Shilei, et al.
Publicado: (2020)

Evolution of Cross-Neutralizing Antibody Specificities to the CD4-BS and the Carbohydrate Cloak of the HIV Env in an HIV-1-Infected Subject
por: Mikell, Iliyana, et al.
Publicado: (2012)

Progress toward active or passive HIV-1 vaccination
por: Escolano, Amelia, et al.
Publicado: (2017)

Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies
por: Barnes, Christopher O., et al.
Publicado: (2020)

Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
por: Hurlburt, Nicholas K., et al.
Publicado: (2020)

SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity
por: Zhang, Fengwen, et al.
Publicado: (2023)

Dynamic Regulation of Tfh Selection During the Germinal Center Reaction
por: Merkenschlager, Julia, et al.
Publicado: (2021)

Anti-idiotypic antibodies elicit anti-HIV-1–specific B cell responses
por: Dosenovic, Pia, et al.
Publicado: (2019)

B cell receptor signaling in germinal centers prolongs survival and primes B cells for selection
por: Chen, Spencer T., et al.
Publicado: (2023)

A single injection of crystallizable fragment domain–modified antibodies elicits durable protection from SHIV infection
por: Gautam, Rajeev, et al.
Publicado: (2018)

Germinal center–dependent and –independent memory B cells produced throughout the immune response
por: Viant, Charlotte, et al.
Publicado: (2021)

Sequencing, cloning, and antigen binding analysis of monoclonal antibodies isolated from single mouse B cells
por: Viant, Charlotte, et al.
Publicado: (2021)

Correction: Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
por: Hoot, Sam, et al.
Publicado: (2013)

Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
por: Hoot, Sam, et al.
Publicado: (2013)

Durable protection against repeated penile exposures to simian-human immunodeficiency virus by broadly neutralizing antibodies
por: Garber, David A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5l4gv0ahnivohuqiet8739phhm